Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Indonesian Adults, Adolescents, Children and Infants (Phase II)
Phase of Trial: Phase II
Latest Information Update: 07 Sep 2018
At a glance
- Drugs Typhoid vaccine Vi DT conjugate International Vaccine Institute/Incepta/SK Bioscience/PT Biofarma (Primary)
- Indications Typhoid
- Focus Adverse reactions
- Sponsors PT Bio Farma
- 28 Aug 2018 Planned primary completion date changed from 27 Apr 2018 to 31 Dec 2018.
- 28 Aug 2018 Status changed from not yet recruiting to recruiting.
- 12 Mar 2018 New trial record